Your browser doesn't support javascript.
loading
Optimal regimen of levetiracetam for prevention of busulfan-induced seizure in patients undergoing hematopoietic stem cell transplantation: A review of available evidence.
Tavajohi, Rayeheh; Shahrami, Bita; Rostami, Tahereh; Kiumarsi, Azadeh; Honarmand, Hooshyar; Hadjibabaie, Molouk.
Afiliación
  • Tavajohi R; Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Shahrami B; Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Rostami T; Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Kiumarsi A; Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Honarmand H; Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Hadjibabaie M; Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
J Oncol Pharm Pract ; 29(4): 927-933, 2023 Jun.
Article en En | MEDLINE | ID: mdl-36843563
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Busulfano / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Guideline / Observational_studies Límite: Adult / Child / Humans Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2023 Tipo del documento: Article País de afiliación: Irán
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Busulfano / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Guideline / Observational_studies Límite: Adult / Child / Humans Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2023 Tipo del documento: Article País de afiliación: Irán